STRUCTURED SMBG IN IRANIAN PEOPLE WITH TYPE 2 DIABETES: A COST CONSEQUENCE ANALYSIS

被引：0
|
作者：
Aghili, R. [1 ]
Khamseh, M. E. [1 ]
Malek, M. [1 ]
Yarahmadi, S. [2 ]
Farshchi, A. [1 ]
机构：
[1] Univ Tehran Med Sci, Tehran, Iran
[2] Minist Hlth & Med Educ, Tehran, Iran
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.897
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A353 / A353
页数：1
相关论文
共 50 条
  • [1] Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis
    Rokhsareh Aghili
    Mohammad E Khamseh
    Mojtaba Malek
    Shahin Yarahmadi
    Amir Farshchi
    [J]. DARU Journal of Pharmaceutical Sciences, 20
  • [2] Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis
    Aghili, Rokhsareh
    Khamseh, Mohammad E.
    Malek, Mojtaba
    Yarahmadi, Shahin
    Farshchi, Amir
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 20
  • [3] STRUCTURED SMBG AS A MEASURE OF GLYCEMIC VARIABILITY IN PERSONS WITH TYPE 2 DIABETES
    Makkar, B.
    Soota, K.
    Sharma, J.
    Chawla, R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A196 - A196
  • [4] The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus
    Farshchi A.
    Esteghamati A.
    Sari A.A.
    Kebriaeezadeh A.
    Abdollahi M.
    Dorkoosh F.A.
    Khamseh M.E.
    Aghili R.
    Keshtkar A.
    Ebadi M.
    [J]. Journal of Diabetes & Metabolic Disorders, 13 (1):
  • [5] ANALYSIS OF COST DRIVERS IN STRUCTURED SMBG IN POORLY CONTROLLED, NON-INSULIN TREATED TYPE-2 DIABETES: RESULTS FROM THE STEP STUDY
    Myers, J.
    Berndt, K.
    Wegmann, N.
    Rees, C.
    Mast, O.
    Wagner, R.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A82 - A82
  • [6] Structured SMBG intervention in patients with non insulin treated type 2 diabetes: the PRISMA study
    Giorgino, F.
    Scavini, M.
    Ceriello, A.
    Cucinotta, D.
    Tiengo, A.
    Bonizzoni, E.
    Marino, R.
    Bosi, E.
    [J]. DIABETOLOGIA, 2012, 55 : S424 - S424
  • [7] EXPERIENCES OF SMBG ADVISORS IN TYPE 2 DIABETES
    Franc, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A8 - A8
  • [8] EFFECTS OF CUSTOMISED STRUCTURED SMBG ON GLYCEMIC CONTROL IN PEOPLE WITH DIABETES OVER 10 YEARS
    Kesavadev, J.
    Shankar, A.
    Jothydev, K.
    Krishnan, G.
    Saboo, B.
    Joshi, S.
    Sanal, G.
    Rajalekshmi, S.
    Basanth, A.
    Jothydev, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A206 - A207
  • [9] Development and validation of diabetes empowerment questionnaire in Iranian people with type 2 diabetes
    Aghili, R.
    Khamseh, M. E.
    Malek, M.
    Banikarimi, A. S.
    Baradaran, H. R.
    Valojerdi, A. Ebrahim
    [J]. INTERNATIONAL NURSING REVIEW, 2013, 60 (02) : 267 - 273
  • [10] A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension
    Palmer, Andrew J.
    Valentine, William J.
    Tucker, Daniel M. D.
    Ray, Joshua A.
    Roze, Stephane
    Annemans, Lieven
    Lapuerta, Pablo
    Chen, Roland
    Gabriel, Sylvie
    Carita, Paulo
    Rodby, Roger A.
    de Zeeuw, Dick
    Parving, Hans-Henrik
    Laville, Maurice
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2095 - 2100
12345